Thanks for this post! I love a good research agenda. Some other relevant bits of work:
The 2019 Global Priorities Institute Workshop on the Economics of Catastrophe, which included Bridget Williams on “Catastrophic Risks from Biotechnology” as well as a number of interesting-sounding general topics (e.g. Ilan Noy on “What Can Mainstream Economics Ideas Add to the Conversation?”)
I see some overlaps with the Legal Priorities Project research agenda for synthetic biology, as it has sections on on Pandemic Finance and Access and Benefits-Sharing
Thanks for this post! I love a good research agenda. Some other relevant bits of work:
The 2019 Global Priorities Institute Workshop on the Economics of Catastrophe, which included Bridget Williams on “Catastrophic Risks from Biotechnology” as well as a number of interesting-sounding general topics (e.g. Ilan Noy on “What Can Mainstream Economics Ideas Add to the Conversation?”)
Lennart Stern (Paris School of Economics) has a paper on Optimal Subsidies for Home Delivery in Times of COVID-19 and is apparently drafting something on “optimal pandemic insurance for global outbreak response funds with endogenous funding”
I see some overlaps with the Legal Priorities Project research agenda for synthetic biology, as it has sections on on Pandemic Finance and Access and Benefits-Sharing